CME Group announced a realignment of its FX futures, options, cash and over-the-counter FX businesses into a single unit led by Paul Houston, who has overseen CME Group’s futures and options business for seven years. Under the new structure, Houston will serve as Global Head of FX Products and will be responsible for the company’s FX derivatives markets as well as its EBS cash markets business. Jeff Ward, Global Head of EBS, will be leaving CME Group in September. “With the adoption of a more integrated FX business model that can better operate across futures, options, cash and OTC markets, we will significantly expand trading opportunities for our clients, while also delivering increased efficiencies and an enhanced ability to introduce new products in the dynamic FX marketplace,” said Tim McCourt, Senior Managing Director, Head of Financial & OTC Products, CME Group.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CME:
- CME Group exec Holzrichter sells 6,000 class A shares
- CME Group Declares Quarterly Dividend
- CME Group reached ADV of 19.9M contracts in July
- DAPP: This Red-Hot Crypto ETF Has Its Flaws
- BITQ: This Crypto ETF Has Nearly Tripled YTD. Is It Worth Buying?
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue